4
Changes in Ownership
PALVELLA THERAPEUTICS, INC. Filed Acc 0001104659-26-006237
Chief Operating Officer sold 4,302 shares at an average $97.63 ($419,983)
- Chief Operating Officer acquired 4,302 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goin Kathleen · Chief Operating Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,154 | $7.14 | $15,380 | 2,154 | D |
| 2026-01-21 | Exercise or conversion : show line 2 in the form 10b5-1 | +2,148 | $9.08 | $19,504 | 4,302 | D |
| 2026-01-21 | Sale : show line 3 in the form 10b5-1 | −553 | $95.49 | $52,806 | 3,749 | D |
| 2026-01-21 | Sale : show line 4 in the form 10b5-1 | −3,749 | $97.94 | $367,177 | 0 | D |
| Open-market sales · 4,302 sh · avg $97.63 · $419,983 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-21 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −2,154 | 19,397 | D |
| 2026-01-21 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −2,148 | 19,332 | D |
Loading xslF345X05/tm263925-1_4seq1.xml…